Cognition Therapeutics CGTX
NASDAQ CGTX
$0.93 +0.04 (+4.49%)
At close: Oct 2, 2026 · 4:00 PM EDT

Cognition Therapeutics (CGTX) Selling, General & Administrative (2020 - 2026)

Updated

Cognition Therapeutics (CGTX) posted Selling, General & Administrative of $2.64 million for Q2 2026, up 5.8% from $2.5 million a year earlier but down 2.1% from the prior quarter.

Analysis

Cognition Therapeutics (CGTX) Selling, General & Administrative (2020 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Cognition Therapeutics was $10.46 million, down 6.0% year-over-year; for FY2025, it was $10.61 million, down 13.7% from FY2024.

  • Annual Selling, General & Administrative shows a five-year compound annual growth rate of 18.6% (FY2020 to FY2025).
  • In prior years, Cognition Therapeutics' Selling, General & Administrative was $12.29 million in FY2024 (-9.2%), $13.53 million in FY2023 (+2.3%), $13.23 million in FY2022 (+31.9%) and $10.03 million in FY2021 (+121.8%).
  • Quarterly Selling, General & Administrative has run from a low of $1.55 million in Q3 2021 to a high of $6.24 million in Q4 2021 over five years.
  • On a year-over-year basis, Selling, General & Administrative increased in 1 of the last eight quarters, with an average decline of 10.6%.
  • The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q4 2021, with growth of 648.5%; the weakest was Q4 2022, with a decline of 50.0%.
  • According to Business Quant data, Selling, General & Administrative for the three prior quarters was $2.7 million (Q1 2026), $2.52 million (Q4 2025) and $2.6 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Cognition Therapeutics 88.40 Mn 88.40 Mn - 2.64 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.64 Mn
Mar 31, 2026 2.70 Mn
Dec 31, 2025 2.52 Mn
Sep 30, 2025 2.60 Mn
Jun 30, 2025 2.50 Mn
Mar 31, 2025 2.99 Mn
Dec 31, 2024 2.57 Mn
Sep 30, 2024 3.07 Mn
Jun 30, 2024 3.10 Mn
Mar 31, 2024 3.55 Mn
Dec 31, 2023 3.59 Mn
Sep 30, 2023 3.08 Mn
Jun 30, 2023 3.32 Mn
Mar 31, 2023 3.54 Mn
Dec 31, 2022 3.12 Mn
Sep 30, 2022 4.36 Mn
Mar 31, 2022 2.90 Mn
Dec 31, 2021 6.24 Mn
Sep 30, 2021 1.55 Mn
Dec 31, 2020 833,000.00
API Access

Cognition Therapeutics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=CGTX&period=max&api_key=YOUR_API_KEY